Effects of ghrelin on pulmonary NOD2 mRNA expression and NF-κB activation when protects against acute lung injury in rats challenged with cecal ligation and puncture

International Immunopharmacology

Volumn 13, Issue 4, 2012, Pages 440-445

  Peng, Zhiyou ^a,b   Zhu, Yinggang ^c   Zhang, Yulong ^d   Wilhelmsen, Kevin ^e   Jia, Chenfei ^a   Jin, Jue ^a   Xue, Qingsheng ^a   Feng, Xiaomei ^a   Zhang, Fujun ^a   Yu, Buwei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ghrelin; Nuclear factor kappa B; Nucleotide binding oligomerization domain 2; TNF

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GHRELIN; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; TRANSCRIPTION FACTOR RELA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CECAL LIGATION AND PUNCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEMODYNAMICS; HISTOPATHOLOGY; INTESTINE INJURY; LIGATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PUNCTURE; RAT; SIGNAL TRANSDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CECUM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GHRELIN; HUMANS; LIGATION; MALE; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; PUNCTURES; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION;

EID: 84862160338     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.006     Document Type: Article

References (42)

1. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150
2. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
3. J. Tian, Y. Wang, Z. He, Y. Gao, J.E. Rundhaug, and X. Wang Hydroxyethyl starch (130 kD) inhibits toll-like receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide Anesth Analg 113 2011 112 119
4. M.S. Frutuoso, J.I. Hori, M.S. Pereira, D.S. Junior, F. Sonego, and K.S. Kobayashi The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila Microbes Infect 12 2010 819 827
5. M. Hasegawa, Y. Fujimoto, P.C. Lucas, H. Nakano, K. Fukase, and G. Nunez A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation EMBO J 27 2008 373 383
6. J.G. Magalhaes, J. Lee, K. Geddes, S. Rubino, D.J. Philpott, and S.E. Girardin Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands Eur J Immunol 41 2011 1445 1455
7. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 2002 725 734
8. F. Arnalich, E. Garcia-Palomero, J. Lopez, M. Jimenez, R. Madero, and J. Renart Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis Infect Immun 68 2000 1942 1945
9. J. Brenmoehl, H. Herfarth, T. Gluck, F. Audebert, S. Barlage, and G. Schmitz Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients Intensive Care Med 33 2007 1541 1548
10. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
11. J.T. Wu, and J.G. Kral Ghrelin: integrative neuroendocrine peptide in health and disease Ann Surg 239 2004 464 474
12. R. Wu, M. Zhou, X. Cui, H.H. Simms, and P. Wang Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis Am J Physiol Heart Circ Physiol 287 2004 H1296 H1302
13. R. Wu, M. Zhou, P. Das, W. Dong, Y. Ji, and D. Yang Ghrelin inhibits sympathetic nervous activity in sepsis Am J Physiol Endocrinol Metab 293 2007 E1697 E1702
14. V.D. Dixit, E.M. Schaffer, R.S. Pyle, G.D. Collins, S.K. Sakthivel, and R. Palaniappan Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells J Clin Invest 114 2004 57 66
15. R. Wu, W. Dong, X. Cui, M. Zhou, H.H. Simms, and T.S. Ravikumar Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve Ann Surg 245 2007 480 486
16. R. Wu, W. Dong, M. Zhou, X. Cui, H. Hank Simms, and P. Wang Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1 Cardiovasc Res 68 2005 318 326
17. R. Wu, W. Dong, M. Zhou, F. Zhang, C.P. Marini, and T.S. Ravikumar Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats Am J Respir Crit Care Med 176 2007 805 813
18. D. Rittirsch, M.S. Huber-Lang, M.A. Flierl, and P.A. Ward Immunodesign of experimental sepsis by cecal ligation and puncture Nat Protoc 4 2009 31 36
19. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
20. J.A. Kellum, L. Kong, M.P. Fink, L.A. Weissfeld, D.M. Yealy, and M.R. Pinsky Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med 167 2007 1655 1663
21. C.A. Gogos, E. Drosou, H.P. Bassaris, and A. Skoutelis Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options J Infect Dis 181 2000 176 180
22. N.C. Riedemann, R.F. Guo, and P.A. Ward The enigma of sepsis J Clin Invest 112 2003 460 467
23. L.B. Ware Pathophysiology of acute lung injury and the acute respiratory distress syndrome Semin Respir Crit Care Med 27 2006 337 349
24. W.Y. Park, R.B. Goodman, K.P. Steinberg, J.T. Ruzinski, F. Radella II, and D.R. Park Cytokine balance in the lungs of patients with acute respiratory distress syndrome Am J Respir Crit Care Med 164 2001 1896 1903
25. J. Fan, R.D. Ye, and A.B. Malik Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol 281 2001 L1037 L1050
26. K.Y. Yang, J.J. Arcaroli, and E. Abraham Early alterations in neutrophil activation are associated with outcome in acute lung injury Am J Respir Crit Care Med 167 2003 1567 1574
27. S. Jeyaseelan Rip2: a novel therapeutic target for bacteria-induced inflammation? Trends Microbiol 10 2002 356
28. T. Kawai, and S. Akira The roles of TLRs, RLRs and NLRs in pathogen recognition Int Immunol 21 2009 317 337
29. L.L. Bourhis, and C. Werts Role of Nods in bacterial infection Microbes Infect 9 2007 629 636
30. D.S. Wheeler, B. Zingarelli, W.J. Wheeler, and H.R. Wong Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response Recent Pat Inflamm Allergy Drug Discov 3 2009 96 112
31. U. Senftleben, and M. Karin The IKK/NF-kappaB pathway Crit Care Med 30 2002 S18 S26
32. M.S. Hayden, and S. Ghosh Shared principles in NF-kappaB signaling Cell 132 2008 344 362
33. C. Hu, L. Sun, Y. Hu, D. Lu, H. Wang, and S. Tang Functional characterization of the NF-kappaB binding site in the human NOD2 promoter Cell Mol Immunol 7 2010 288 295
34. X. Feng, F. Zhang, R. Dong, H. Wang, J. Liu, and X. Liu Effects of hydroxyethyl starch (130 kD) on brain inflammatory response and outcome during normotensive sepsis Int Immunopharmacol 10 2010 859 864
35. X. Feng, B. Ren, W. Xie, Z. Huang, J. Liu, and R. Guan Influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats Acta Anaesthesiol Scand 50 2006 1081 1088
36. X. Feng, W. Yan, X. Liu, M. Duan, X. Zhang, and J. Xu Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats J Surg Res 135 2006 129 136
37. X. Feng, J. Liu, M. Yu, S. Zhu, and J. Xu Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis Clin Chim Acta 376 2007 60 67
38. W.G. Li, D. Gavrila, X. Liu, L. Wang, S. Gunnlaugsson, and L.L. Stoll Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells Circulation 109 2004 2221 2226
39. A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria J Immunol 180 2008 8369 8377
40. T. Kodama, J. Ashitani, N. Matsumoto, K. Kangawa, and M. Nakazato Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection Pulm Pharmacol Ther 21 2008 774 779
41. M.P. Fink Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1 Crit Care Med 37 2009 2483 2485
42. E.Z. Sung, N.F. Da Silva, S.J. Goodyear, P.G. McTernan, R.P. Arasaradnam, and C.U. Nwokolo Ghrelin promotes nuclear factor kappa-B activation in a human B-lymphocyte cell line Mol Biol Rep 38 2011 4833 4838